2025 Basser Center Global Prize Awarded to Ephrat Levy-Lahad Penn Medicine News News Levy-Lahad has been recognized for leading population-based BRCA screening programs. Latest News ALC1 Links Chromatin Accessibility to PARP Inhibitor Response in Homologous Recombination-Deficient Cells Nature Cell Biology News | January 2021 10 Cancer Super Survivors You Need to Follow on Instagram Right Now Parade News | December 2020 Everviolet Chats: Erika Stallings Everviolet News | December 2020 Real-World Integration of Genomic Data into the Electronic Health Record: the PennChart Genomics Initiative Nature News | December 2020 Penn’s Basser Center for BRCA Awards 2020 Basser Global Prize to Bella Kaufman from Israel’s Sheba Medical Center Penn Medicine News News | December 2020 Diagnostic Radiation Below the Waist May Increase Risk for Testicular Cancer Healio News | November 2020 Spotting These Pancreatic Cancer Symptoms Could Save Your Life Yahoo Lifestyle News | November 2020 Global Connections: COVID & CANCER Global Connections News | October 2020 Penn Medicine Researchers Receive $5.4 million Grant to Find Genetic Drivers of Testicular Cancer Penn Medicine News News | October 2020 Pod is a Woman: Breast Cancer Awareness Pod is a Woman News | October 2020 Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers JCO Precision Oncology News | September 2020 Olaparib and Durvalumab in Patients with Germline BRCA-Mutated Metastatic Breast Cancer The Lancet News | August 2020 Study Finds New Mutation in Ashkenazi Jews Jewish Exponent News | July 2020 Study Finds New Mutation in Ashkenazi Jews Jewish Exponent News | July 2020 Genetic Counseling for Cancer Shifts to a New Era of Virtual Care Cure Magazine News | June 2020 Angela R. Bradbury, MD, on Telemedicine in Genetic Counseling Cancer Network News | May 2020 When Isolation is Worse Than Death: a Philly Oncologist on Cancer Patients and COVID-19 l Opinion Philadelphia Inquirer News | May 2020 EMBRACA Trial Shows No Overall Survival Difference Between Talzenna, Chemotherapy Arms Precision Oncology News News | April 2020 Pagination First page« First Previous page‹‹ … Page6 Page7 Page8 Page9 Current page10 Page11 Page12 Page13 Page14 … Next page›› Last pageLast »
2025 Basser Center Global Prize Awarded to Ephrat Levy-Lahad Penn Medicine News News Levy-Lahad has been recognized for leading population-based BRCA screening programs.
ALC1 Links Chromatin Accessibility to PARP Inhibitor Response in Homologous Recombination-Deficient Cells Nature Cell Biology News | January 2021
Real-World Integration of Genomic Data into the Electronic Health Record: the PennChart Genomics Initiative Nature News | December 2020
Penn’s Basser Center for BRCA Awards 2020 Basser Global Prize to Bella Kaufman from Israel’s Sheba Medical Center Penn Medicine News News | December 2020
Diagnostic Radiation Below the Waist May Increase Risk for Testicular Cancer Healio News | November 2020
Penn Medicine Researchers Receive $5.4 million Grant to Find Genetic Drivers of Testicular Cancer Penn Medicine News News | October 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers JCO Precision Oncology News | September 2020
Olaparib and Durvalumab in Patients with Germline BRCA-Mutated Metastatic Breast Cancer The Lancet News | August 2020
When Isolation is Worse Than Death: a Philly Oncologist on Cancer Patients and COVID-19 l Opinion Philadelphia Inquirer News | May 2020
EMBRACA Trial Shows No Overall Survival Difference Between Talzenna, Chemotherapy Arms Precision Oncology News News | April 2020
